Wealthcare Advisory Partners LLC Amarin Corp Plcuk Transaction History

Wealthcare Advisory Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$4.26 - $6.5 $5,580 - $8,515	-1,310 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$5.03 - $8.8 $6,589 - $11,528	1,310 New	1,310 $8,000
Q2 2020 Jul 29, 2020	SELL	$4.78 - $8.26 $9,846 - $17,015	-2,060 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$4.0 - $21.53 $1,900 - $10,226	475 Added 29.97%	2,060 $8,000
Q4 2019 Jan 29, 2020	BUY	$13.94 - $24.12 $14,985 - $25,929	1,075 Added 210.78%	1,585 $34,000
Q3 2019 Oct 17, 2019	BUY	$13.89 - $23.16 $7,083 - $11,811	510 New	510 $8,000
Q2 2019 Jul 30, 2019	SELL	$16.27 - $20.51 $32,540 - $41,020	-2,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$12.61 - $22.33 $25,220 - $44,660	2,000 New	2,000 $42,000

181

69.6M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $210M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.